HIGHLIGHTS
- who: Murine Laryngeal Cancer and colleagues from the The First Department of Otorhinolaryngology, The Second Hospital of Hebei Medical University, No, Heping West Road, Shijiazhuang, Hebei, China have published the article: Oxaliplatin Induces Immunogenic Cell Death in Human and Murine Laryngeal Cancer, in the Journal: Journal of Oncology of 12/09/2022
- what: This study was designed to explore the efficacy of oxaliplatin on and elucidate the underlying mechanisms. This study investigated the antitumor activities of oxaliplatin against laryngeal cancer and its underlying mechanism.
- how: In vivo data showed that oxaliplatin suppressed tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.